Nurse Practitioner, Family · Aliquippa, PA
NPI
1285725242
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2360 Hospital Dr
Aliquippa, PA, 15001
Phone (724) 378-0830
Medicare paid, 2024
$17K
276 services
Medicare patients, 2024
122
Average age 72
Drug cost, 2024
$3.0M
4,930 prescriptions
Company payments, 2025
$52.23
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen B Mayo was code 99214 (office e&m - established), 194 times for 107 patients. In total Karen B Mayo billed 276 services in 8 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 194 | 107 | $72.94 | $14K |
| 95251 Test - Miscellaneous | Office | 45 | 37 | $22.31 | $1,004 |
| 99213 Office E&M - Established | Office | 28 | 21 | $41.98 | $1,175 |
By year: 2022 $22K for 333 services; 2023 $23K for 339 services; 2024 $17K for 276 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen B Mayo prescribed most often to Medicare patients was Levothyroxine Sodium, with 463 prescriptions and refills. In total Karen B Mayo wrote 4,930 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 463 | 945 | 102 | $5,506 |
| Jardiance Empagliflozin | 319 | 549 | 67 | $317K |
| Ozempic Semaglutide | 239 | 374 | 51 | $351K |
| Trulicity Dulaglutide | 231 | 307 | 45 | $289K |
| Metformin Hcl Generic | 228 | 583 | 66 | $1,735 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 214 | 406 | 46 | $328K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 207 | 420 | 53 | $180K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 195 | 500 | 74 | $24K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 190 | 368 | 49 | $32K |
| Humalog Kwikpen U-100 Insulin Lispro | 163 | 288 | 53 | $64K |
| Novolog Flexpen Insulin Aspart | 151 | 287 | 56 | $52K |
| Tresiba Flextouch U-200 Insulin Degludec | 147 | 298 | 38 | $190K |
| Tradjenta Linagliptin | 127 | 233 | 23 | $115K |
| Synthroid Levothyroxine Sodium | 126 | 279 | 28 | $6,270 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 104 | 201 | 26 | $163K |
Brand drugs: 3,016 claims; generic drugs: 1,380 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen B Mayo $52.23 ($52.23 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $28.35.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.